These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17152022)

  • 41. Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection.
    Kan VL; Manischewitz J; King LR; Golding H
    AIDS; 2007 Feb; 21(4):521-4. PubMed ID: 17301573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Smallpox immunity in repeatedly vaccinated persons].
    Cumbrowski J
    Z Gesamte Hyg; 1977 Feb; 23(2):128-3. PubMed ID: 868149
    [No Abstract]   [Full Text] [Related]  

  • 43. Interpreting the epidemiology of postexposure vaccination against smallpox.
    Nishiura H; Eichner M
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):219-26. PubMed ID: 17321212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic and genetic diversity of the traditional Lister smallpox vaccine.
    Garcel A; Perino J; Crance JM; Drillien R; Garin D; Favier AL
    Vaccine; 2009 Jan; 27(5):708-17. PubMed ID: 19059294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MMA warns against "pox parties".
    Minn Med; 2012 Feb; 95(2):28. PubMed ID: 22474890
    [No Abstract]   [Full Text] [Related]  

  • 46. [On the evaluation of immunity to smallpox in soldiers during the 1st year of service by skin tests and revaccination].
    Popov NV
    Voen Med Zh; 1965 May; 5():70-3. PubMed ID: 5870090
    [No Abstract]   [Full Text] [Related]  

  • 47. [The relationship between cutaneous reactions and humoral immunity after smallpox revaccination in people aged 20-21].
    Topciu V; Voiculescu D; Moldovan E; Giurca A; Plavoşin L; Nica A; Săcăleanu M
    Zentralbl Bakteriol Orig B; 1972 Aug; 156(1):105-14. PubMed ID: 4661951
    [No Abstract]   [Full Text] [Related]  

  • 48. Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice.
    Melamed S; Paran N; Katz L; Ben-Nathan D; Israely T; Schneider P; Levin R; Lustig S
    Vaccine; 2007 Nov; 25(45):7743-53. PubMed ID: 17928110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safer pox protection.
    Boyce N
    US News World Rep; 2004 Mar 22-29; 136(10):59. PubMed ID: 15069905
    [No Abstract]   [Full Text] [Related]  

  • 50. [The results of immunizing people who have been ill with natural smallpox with smallpox vaccine].
    Khomiakov AI
    Vopr Virusol; 1969; 14(4):492-3. PubMed ID: 5356195
    [No Abstract]   [Full Text] [Related]  

  • 51. New generation smallpox vaccines: a review of preclinical and clinical data.
    Artenstein AW
    Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intranasal cowpox virus infection of the mouse as a model for preclinical evaluation of smallpox vaccines.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2007 Jun; 25(25):4809-17. PubMed ID: 17499401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Assessment of the smallpox antibody titre in repeatedly vaccinated subjects].
    Cumbrowski J; Hölzer E; Müller A; Wachtel S
    Z Gesamte Hyg; 1977 Oct; 23(10):755-8. PubMed ID: 602303
    [No Abstract]   [Full Text] [Related]  

  • 54. [Correlation between serum antibodies and skin reaction after smallpox revaccination].
    Topciu V; Pavloşin-Babuşceac L; Csáky N; Radu M; Mageanu O; Hansell S; Reinert O; Dan G; Suta C; Preda E; Comşulea L
    Arch Roum Pathol Exp Microbiol; 1966 Dec; 25(4):866-74. PubMed ID: 5983321
    [No Abstract]   [Full Text] [Related]  

  • 55. Five years after 9/11-fearing smallpox, ... and the vaccine against it.
    Ruef C
    Infection; 2006 Oct; 34(5):239-40. PubMed ID: 17033745
    [No Abstract]   [Full Text] [Related]  

  • 56. Studies on the standardization of smallpox vaccine. II. An assay with a rabbit immunized beforehand by active immunization.
    Yaoi H; Yamanouchi T
    Yokohama Med Bull; 1967 Aug; 18(4):107-15. PubMed ID: 6081783
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of pharyngeal shedding of vaccinia following smallpox vaccination.
    Talbot TR; Peters J; Wright PF; Edwards KM
    Am J Infect Control; 2007 Sep; 35(7):486-8. PubMed ID: 17765564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smallpox revaccination of 21000 first responders in Israel: lessons learned.
    Anis E; Leventhal A; Slater PE; Shinar E; Yahalom V; Smetana Z; Zach R; Reznikovich S; Mendelson E; Danon Y; Lev B
    Int J Infect Dis; 2009 May; 13(3):403-9. PubMed ID: 19010077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [On some problems in the use of viral vaccines in Bulgaria].
    Gantschewa Z
    Zentralbl Bakteriol Orig; 1965 Dec; 198(4):416-22. PubMed ID: 5875406
    [No Abstract]   [Full Text] [Related]  

  • 60. A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.
    Johnson MC; Damon IK; Karem KL
    J Virol Methods; 2008 Jun; 150(1-2):14-20. PubMed ID: 18387679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.